|

Resistance Exercise in Patients With Ocular Melanoma

RECRUITINGN/ASponsored by University of Valencia
Actively Recruiting
PhaseN/A
SponsorUniversity of Valencia
Started2025-02-01
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06970236

Summary

Choroidal melanoma (CM) is one of the most common intraocular cancers worldwide. During treatment with episcleral brachytherapy, patients require a week of hospitalization in isolation. The primary aim of this study will be to investigate the effects of resistance training during hospitalization on health-related blood biomarkers in CM patients. Our secondary aim will be to assess changes in physical function tests, quality of life and anxiety and depression. Candidates for this study will be patients undergoing CM treatment at the "Hospital Universitari i Politècnic La Fe" of Valencia.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults with Choroidal Melanoma diagnose and treated with plaque brachytherapy undergoing in "Hospital Universitari i Politècnic La Fe" (Valencia).

Exclusion Criteria:

* Present a health status that forbids high intensity resistance training.
* Have any unsteady cardiac illness.
* Have serious metabolic disorder.
* Have any important orthopaedic disorder impeding exercise.

Conditions2

CancerOcular Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.